These results together with public data from GTEx, and TCGA, suggests that the SNP does not affect the transcription of LRIG1 and that differential expression of this gene does not explain the increased risk of glioma development conferred by rs11706832. The gene discussed is LRIG1; the disease is central nervous system cancer.